CompoAtlas

Uberzinc

Natural health product licensed in Canada

Licence holder
Poliquin Performance Center 2 LLC dba Poliquin Group
NPN or DIN-HM
80073432
Status
Active licence
Licence date
1 November 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Zinc

Source : Orotate de zinc

30 milligramme30,000 µg
Zinc

Source : Aspartate de zinc

30 milligramme30,000 µg

Non-medicinal ingredients

Silice, Silicate de magnésium, Cellulose, Palmitate d'ascorbyle, Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Zinc helps in connective tissue formation. Zinc helps to maintain healthy skin. Zinc helps to maintain immune function. Zinc helps in energy metabolism and tissue formation. Zinc helps to maintain normal DNA synthesis. Zinc helps to maintain normal acid-base metabolism. Zinc helps to maintain healthy bones, hair, nail and/or skin. Zinc helps to maintain the body's ability to metabolize nutrients.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80073432

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line